Response to article by Johnna Perdrizet et al.,“Cost-effectiveness analysis of replacing the 10-valent pneumococcal conjugate vaccine (PCV10) with the 13-valent pneumococcal conjugate vaccine (PCV13) in Brazil infants”

Response to article by Johnna Perdrizet et al.,“Cost-effectiveness analysis of replacing the 10-valent pneumococcal conjugate vaccine (PCV10) with the 13-valent pneumococcal conjugate vaccine (PCV13) in Brazil infants”

Bibliographic Details
Main Authors: Jorge A. Gómez, Thatiana de Jesus Pereira Pinto, Javier Nieto Guevara, Tatiana Guimarães de Noronha
Format: Article
Language:English
Published: Taylor & Francis Group 2022-01-01
Series:Human Vaccines & Immunotherapeutics
Online Access:http://dx.doi.org/10.1080/21645515.2021.1894898

Internet

http://dx.doi.org/10.1080/21645515.2021.1894898

Similar Items